A Preclinical Study of Syk Inhibition as a Immunomodulator for Glioblastoma

Project: Research project

Project Details

StatusActive
Effective start/end date9/1/248/31/26

Funding

  • Northwestern Memorial Hospital (Letter 10/24/24)